Your browser doesn't support javascript.
loading
Comparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?
Balighi, Kamran; Daneshpazhooh, Maryam; Mahmoudi, HamidReza; Badakhsh, Mehrnoosh; Teimourpour, Amir; Ehsani, Amir Houshang; Azizpour, Arghavan; Akbari, Zahra; Mahdavinia, Mostafa; Ghasemiadl, Mojtaba; Tavakolpour, Soheil.
Afiliación
  • Balighi K; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Mahmoudi H; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Badakhsh M; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Teimourpour A; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Ehsani AH; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Azizpour A; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Akbari Z; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Mahdavinia M; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Ghasemiadl M; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran.
  • Tavakolpour S; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Vahdate-Eslami Square, Tehran, 11996, Iran. Soheil.tavakolpour@gmail.com.
Arch Dermatol Res ; 311(1): 63-69, 2019 Jan.
Article en En | MEDLINE | ID: mdl-30506422
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pénfigo / Rituximab / Factores Inmunológicos Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Arch Dermatol Res Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pénfigo / Rituximab / Factores Inmunológicos Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Arch Dermatol Res Año: 2019 Tipo del documento: Article